Nickel Allergy Contact Dermatitis

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2021-12-17
Clinical Trial Update: Study of the Intradermal Injection of rHuPH20 or Placebo in Participants With Nickel Allergic Contact Dermatitis [Phase 2]
Phase 2 study evaluating intradermal rHuPH20 versus placebo in nickel allergic contact dermatitis completed with results posted in 2021.